Glucotrack, Inc. (GCTK) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated October 31, 2025, reports on a special meeting of stockholders convened by Glucotrack, Inc. The filing addresses the outcome of the meeting held on October 31, 2025, at 12:00 p.m. Eastern Time, and the subsequent adjournment of said meeting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting matters.
Material Changes and Voting Results
The special meeting failed to achieve a quorum required to conduct business. As of the record date (September 23, 2025), there were 899,410 shares of common stock outstanding. Only 16.4% of these shares were represented at the meeting.
Stockholders voted on a proposal to adjourn the meeting to solicit additional proxies. The results were as follows:
- Votes For: 136,928
- Votes Against: 8,655
- Abstain/Withhold: 1,923
The Adjournment Proposal was approved. The meeting has been rescheduled to November 7, 2025, at 12:00 p.m. Eastern Time.
Guidance, Outlook, and Future Actions
At the adjourned meeting on November 7, 2025, stockholders will be asked to vote on the "Issuance Proposal," details of which are contained in the definitive proxy statement filed on October 3, 2025. The meeting will be held virtually.
Investor Verification Checklist
- Verify the details of the "Issuance Proposal" in the proxy statement filed on October 3, 2025.
- Confirm the attendance and voting results for the adjourned meeting on November 7, 2025.
- Monitor the company's ability to secure a quorum for the rescheduled meeting.